• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BRACCO INJENEERING SA EMPOWERCTA+; INJECTOR, CONTRAST MEDIUM, AUTOMATIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BRACCO INJENEERING SA EMPOWERCTA+; INJECTOR, CONTRAST MEDIUM, AUTOMATIC Back to Search Results
Model Number EMPOWERCTA+
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Air Embolism (1697)
Event Date 11/11/2023
Event Type  Injury  
Event Description
On (b)(6), 2023, (b)(4) became aware that after a computed tomography (ct) scan of the abdomen and pelvis with an empowercta+ injection system, serial number (b)(6), the technologist noticed an unknown amount of isovue 300 contrast on the floor from a leaking connection between the injector tubing and the intravenous (iv) line.An unknown amount of air was later observed in the imaging in the patient's left ventricle.On (b)(6) 2023, (b)(4) became aware the patient was transferred to another hospital due to the visualization of air on the ct images.The patient was reported to have recovered on (b)(6) 2023.
 
Manufacturer Narrative
H3: on november 12, 2023, testing was performed on the empowercta+ injector, system serial number (b)(6) by a bracco service technician.The injection system was functionally tested and met the pre-established specifications.The consumable kits used during the event were not available for evaluation; the consumable kits had been discarded by the user facility.Also, lot information for the consumable kits used during the event were not provided so no further investigation can be conducted on the consumable kits.A device history record review will be completed for the empowercta+ injector system, serial number (b)(6).A review of the copies of the ct scans provided by the user facility will be completed by bracco's medical advisory board member.Upon completion of the device history record reviews and review of the ct scans, a follow-up report will be submitted to the fda.
 
Manufacturer Narrative
H3: a review of the device history records for empowercta+ injector, system serial number (b)(6), was completed on 28 december 2023.There was no evidence of a quality issue or device malfunction related to the reported event based on the device history record review.Per information provided by the user facility, the cause of the event was most likely due to user error.The ct scans of the patient procedure were provided to acist and reviewed by the acist medical advisory board member.The assessment is as following: the radiographers who carried out the examination did not notice the presence of air at the time of examination.The radiologist who examined the images later called attention to the presence of air.The patient remained asymptomatic during and after the scan but was transferred to a larger and better equipped hospital for observation and follow-up.It is not known if the patient required any medical intervention.It has been well established that volumes of air injected intravenously greater than 25 cc have the potential for serious harm, permanent disability, or death whereas volumes less than 10 cc in adults are considered essentially safe.Based upon examination of the 50 scan images provided, the estimated volume of air is less than 10 cc.Per the empowercta+ user's guide, "the empowercta®+ injector system must be used properly to prevent the risk of an air embolism.Always fill the syringe with the injector pointing fully upward.When the syringe has been filled to the desired volume, all the air should be purged from the syringe and coiled tubing with the injector still in the fully vertical position.Failure to do so may lead to serious injury and/or death." based on acist's investigation, there was no evidence of device malfunction related to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMPOWERCTA+
Type of Device
INJECTOR, CONTRAST MEDIUM, AUTOMATIC
Manufacturer (Section D)
BRACCO INJENEERING SA
46 avenue de sévelin
lausanne,
Manufacturer (Section G)
ACIST MEDICAL SYSTEMS
7905 fuller road
eden prairie MN 55344
Manufacturer Contact
teresa butler
7905 fuller road
eden prairie, MN 55344
6125006492
MDR Report Key18414463
MDR Text Key331577210
Report Number3004753774-2023-00005
Device Sequence Number1
Product Code IZQ
UDI-Device Identifier47630039300904
UDI-Public(01)47630039300904(11)210517
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071378
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEMPOWERCTA+
Device Catalogue Number017285
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/29/2023
Initial Date FDA Received12/28/2023
Supplement Dates Manufacturer Received11/29/2023
Supplement Dates FDA Received01/18/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/17/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
ISOVUE 300
Patient Outcome(s) Hospitalization;
Patient Age45 YR
Patient SexFemale
-
-